Conformational flexibility in the flap domains of ligand-free HIV protease
about
Charting a Path to Success in Virtual ScreeningUnique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance.Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and DarunavirStructure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypesFragment-Based Screen against HIV ProteasePagP Crystallized from SDS/Cosolvent Reveals the Route for Phospholipid Access to the Hydrocarbon RulerContribution of the 80s loop of HIV-1 protease to the multidrug-resistance mechanism: crystallographic study of MDR769 HIV-1 protease variantsCapturing the Reaction Pathway in Near-Atomic-Resolution Crystal Structures of HIV-1 ProteaseSmall Molecule Regulation of Protein Conformation by Binding in the Flap of HIV ProteaseHIV-1 Protease with 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors through Coordinated Structural RearrangementsCrystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compoundsStructures of Darunavir-Resistant HIV-1 Protease Mutant Reveal Atypical Binding of Darunavir to Wide Open FlapsEvidence that the Bacillus subtilis SpoIIGA protein is a novel type of signal-transducing aspartic proteaseStructural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap DynamicsFlap dynamics of plasmepsin proteases: insight into proposed parameters and molecular dynamicsUnderstanding HIV-1 protease autoprocessing for novel therapeutic development.Mining the protein data bank to differentiate error from structural variation in clustered static structures: an examination of HIV protease.Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.Conformation of inhibitor-free HIV-1 protease derived from NMR spectroscopy in a weakly oriented solutionNatural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis.Differential Flap Dynamics in Wild-type and a Drug Resistant Variant of HIV-1 Protease Revealed by Molecular Dynamics and NMR Relaxation.Conformational variation of an extreme drug resistant mutant of HIV protease.Modelling dynamics in protein crystal structures by ensemble refinementPulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.Switches of hydrogen bonds during ligand-protein association processes determine binding kinetics.Atomistic simulations of the HIV-1 protease folding inhibition.Transient HIV-1 Gag-protease interactions revealed by paramagnetic NMR suggest origins of compensatory drug resistance mutations.Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDSEnhanced conformational sampling technique provides an energy landscape view of large-scale protein conformational transitions.Dataset showing the impact of the protonation states on molecular dynamics of HIV protease.A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant.Developing HIV-1 Protease Inhibitors through Stereospecific Reactions in Protein Crystals.Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses.MFPred: Rapid and accurate prediction of protein-peptide recognition multispecificity using self-consistent mean field theory.Crystallisation of wild-type and variant forms of a recombinant plant enzyme β-D-glucan glucohydrolase from barley (Hordeum vulgare L.) and preliminary X-ray analysis.Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility.Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease.Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.Amide hydrogen exchange in HIV-1 subtype B and C proteases--insights into reduced drug susceptibility and dimer stability.Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational sampling.
P2860
Q26779035-AA664B4D-EE3A-4BD7-A5ED-6921D8627487Q27325362-63D6B37F-0C0F-4F2A-9E0C-43135B61854AQ27651021-CB4F4577-75B3-49ED-91CE-6C9CA6BFC633Q27660028-7C310835-EFA2-4398-A4CB-E8EE9A4B8B94Q27663595-56029303-6864-476E-844A-19F32EBEE85EQ27664381-7CDFA8AF-55A9-4E77-9848-5451077266E4Q27668148-8DEDCBCA-C1B2-4EA6-A440-8B233A4A82A4Q27672873-0147D2EE-5557-4A98-BD7E-9061EA7C51FDQ27677124-53D1465F-7C3E-4AD5-BEC3-345CC7D73350Q27677952-2F6B21DF-07EF-4733-B17F-44C021FBDD13Q27678305-00A8B187-8C52-425F-BFAE-B1630B253D88Q27683434-EC373AC2-D857-4A88-9A3A-21D0DCB1449FQ28489003-B822AEA3-878B-40F0-93B1-B3D821C55199Q28555090-FFF02D07-1B1B-4814-9E5D-FA7E16712620Q29014312-94D7433A-3667-40D6-BEC6-78651A5346B8Q33356201-84A52908-84C9-4010-9508-ECB71C5BB25CQ33454752-29EE8466-7243-4C98-9697-16676A078ECEQ33990752-D83620B9-5052-41B3-8A9A-7B951DA43459Q34945073-33ED71D5-73ED-4E29-9F9C-BE19AB5ACD06Q35120811-9EBCA781-1DF5-487E-8640-949DFD07FA90Q36378725-2CF30552-C58E-4BD3-BD56-D5641B8A7260Q36414802-9A1F70F7-39A7-4AD8-83AD-19319E8F0970Q36474046-6AF2D65F-406F-4641-842B-0CA62A85278BQ36593975-336CFF63-7D70-44DA-97DC-D4691889C909Q36640463-99538529-B44C-4DE4-A965-107EDFCA5AEEQ36737204-5EAA87A7-2384-4513-BC48-D0DC1AB66E44Q37398034-D189B62F-0212-4048-BF20-2F6989006874Q38708006-BB22DE3F-0DB4-4C6D-A80D-A6120860ED88Q39300805-4464717A-B9FA-4E8F-82C6-17EA64F3CDBEQ39478529-B76FA5B3-DC4A-4ABE-8BAB-ED36942E1829Q39934806-E992055F-60EA-4FC7-B720-FC03B7BE47ECQ40467926-FF491198-B605-4F78-853F-3182FC22E447Q40766306-A116F553-0204-48F5-A735-3E6A935712B0Q40995571-5DBB8452-396D-45C8-9977-E191F73D0BE3Q41764138-749AA5F2-679C-42C9-BBBF-12F04C0C11C7Q41848680-16A1EA2C-8E6F-4AE8-B47A-84F14F16D1C7Q42146547-D5A3A774-CFC6-45A7-A568-B63EF03ED2C1Q42168520-A87AC3F0-BC03-44E7-9DD4-35429CC9CC75Q42184665-5BECF316-4FDF-47E4-AEC0-0E2273C442CAQ42208913-E9F424DE-1FF1-4683-9857-E006824683A4
P2860
Conformational flexibility in the flap domains of ligand-free HIV protease
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Conformational flexibility in the flap domains of ligand-free HIV protease
@ast
Conformational flexibility in the flap domains of ligand-free HIV protease
@en
Conformational flexibility in the flap domains of ligand-free HIV protease
@nl
type
label
Conformational flexibility in the flap domains of ligand-free HIV protease
@ast
Conformational flexibility in the flap domains of ligand-free HIV protease
@en
Conformational flexibility in the flap domains of ligand-free HIV protease
@nl
prefLabel
Conformational flexibility in the flap domains of ligand-free HIV protease
@ast
Conformational flexibility in the flap domains of ligand-free HIV protease
@en
Conformational flexibility in the flap domains of ligand-free HIV protease
@nl
P2093
P3181
P1476
Conformational flexibility in the flap domains of ligand-free HIV protease
@en
P2093
Bruce E Torbett
C David Stout
Duncan E McRee
Holly Heaslet
John H Elder
Mike Giffin
Robin Rosenfeld
Ying Chuan Lin
P304
P3181
P356
10.1107/S0907444907029125
P577
2007-08-01T00:00:00Z